CME Group Inc. (NASDAQ: CME) is 10.42% higher on its value in year-to-date trading and has touched a low of $144.85 and a high of $216.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CME stock was last observed hovering at around $204.78 in the last trading session, with the day’s loss setting it -3.76% off its average median price target of $211.50 for the next 12 months. It is also 16.24% off the consensus price target high of $240.00 offered by 22 analysts, but current levels are -32.25% lower than the price target low of $152.00 for the same period.
Currently trading at $201.02, the stock is -2.18% and -1.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing -1.84% at the moment leaves the stock 11.85% off its SMA200. CME registered 10.59% gain for a year compared to 6-month gain of 27.28%. The firm has a 50-day simple moving average (SMA 50) of $205.57 and a 200-day simple moving average (SMA200) of $186.88.
The stock witnessed a -3.80% loss in the last 1 month and extending the period to 3 months gives it a 12.43%, and is -2.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.55% over the week and 1.58% over the month.
CME Group Inc. (CME) has around 4370 employees, a market worth around $71.77B and $4.88B in sales. Current P/E ratio is 34.23 and Fwd P/E is 27.47. Profit margin for the company is 43.10%. Distance from 52-week low is 38.77% and -7.26% from its 52-week high. The company has generated returns on investments over the last 12 months (6.80%).
CME Group Inc. (CME) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for CME Group Inc. (CME) is a “Overweight”. 22 analysts offering their recommendations for the stock have an average rating of 2.40, where 8 rate it as a Hold and 2 think it is a “Overweight”. 9 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.
CME Group Inc. is expected to release its quarterly report on 08/04/2021 and quarterly earnings per share for the current quarter are estimated at $1.75 with sales reaching $1.25B over the same period.The EPS is expected to shrink by -0.60% this year, but quarterly earnings will post 1.00% year-over-year. Quarterly sales are estimated to shrink -17.70% in year-over-year returns.
CME Group Inc. (CME) Top Institutional Holders
1,468 institutions hold shares in CME Group Inc. (CME), with 1.64M shares held by insiders accounting for 0.46% while institutional investors hold 87.82% of the company’s shares. The shares outstanding are 358.05M, and float is at 354.08M with Short Float at 1.32%. Institutions hold 87.42% of the Float.
The top institutional shareholder in the company is Capital World Investors with over 33.84 million shares valued at $6.16 billion. The investor’s holdings represent 9.42% of the CME Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 28.23 million shares valued at $5.14 billion to account for 7.86% of the shares outstanding. The other top investors are Blackrock Inc. which holds 25.29 million shares representing 7.04% and valued at over $4.6 billion, while State Street Corporation holds 4.59% of the shares totaling 16.49 million with a market value of $3.0 billion.
CME Group Inc. (CME) Insider Activity
A total of 63 insider transactions have happened at CME Group Inc. (CME) in the last six months, with sales accounting for 45 and purchases happening 18 times. The most recent transaction is an insider sale by GEPSMAN MARTIN J, the company’s Director. SEC filings show that GEPSMAN MARTIN J sold 1,500 shares of the company’s common stock on Mar 11 at a price of $205.46 per share for a total of $0.31 million. Following the sale, the insider now owns 27917.0 shares.
CME Group Inc. disclosed in a document filed with the SEC on Mar 05 that Piell Hilda Harris (Sr MD & Chief HR Officer) sold a total of 1,500 shares of the company’s common stock. The trade occurred on Mar 05 and was made at $213.00 per share for $0.32 million. Following the transaction, the insider now directly holds 36704.0 shares of the CME stock.
Still, SEC filings show that on Feb 26, Tully Sean (Sr MD Global Hd Financial & OT) disposed off 10,000 shares at an average price of $201.41 for $2.01 million. The insider now directly holds 19,670 shares of CME Group Inc. (CME).
CME Group Inc. (CME): Who are the competitors?
The company’s main competitors (and peers) include MarketAxess Holdings Inc. (MKTX) that is trading 10.86% up over the past 12 months. Nasdaq Inc. (NDAQ) is 43.56% up on the 1-year trading charts. Short interest in the company’s stock has risen 7.91% from the last report on Apr 14, 2021 to stand at a total of 4.66 million short shares sold with a short interest ratio of 3.2.